Aldeyra Therapeutics Announces Intent to Submit Formal Dispute Resolution Request for Reproxalap to Treat Dry Eye Disease
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| ALDEYRA THERAPEUT (NASDAQ: ALDX) | Delayed: 0.67 -0.06 (8.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.73 | 52 Week High | $8.19 | |||
| Open | $0.74 | 52 Week Low | $3.39 | |||
| Day High | $0.75 | P/E | N/A | |||
| Day Low | $0.66 | EPS | $0.00 | |||
| Volume | 606,566 | |||||
